THE STUDY OF COLISTIN SUSCEPTIBILITY AMONG CARBAPENEM-RESISTANT GRAM-NEGATIVE BACILLI BY BROTH MICRODILUTION METHOD USING READY-TO-USE COLISTIN MIC PLATE KIT

Authors

DOI:

https://doi.org/10.22159/ijcpr.2025v17i4.7037

Keywords:

Carbapenem Resistance, EUCAST, Colistin, Broth Micro Dilution, Ready-to-use

Abstract

Objective: Carbapenem-resistant Gram-negative bacteria (CR-GNB) pose a major threat to the treatment of infectious diseases. There is a recent increase of Colistin use as a last resort antibiotic for carbapenem-resistant and extensively drug-resistant GNB infections. As per EUCAST (2023) and CLSI(2023) guidelines, gradient diffusion or disc diffusion are inappropriate for colistin susceptibility testing and colistin MIC should be performed by broth microdilution method.

The aim of the present study is to isolate Carbapenem-resistant Gram-negative bacilli (CR-GNB) and to detect colistin susceptibility in CR-GNB using commercial broth microdilution plate kit.

Methods: This is a cross-sectional descriptive study conducted at the Department of Microbiology, Andhra Medical College, Visakhapatnam, for a period of 6 mo from October 2023 to March 2024. A total of 58 CR-GNB isolated from 4905 samples were taken for colistin susceptibility testing by the HiMIC plate kit Broth microdilution technique.

Results: This study examined 4905 clinical samples comprising of Urines, Blood, and Exudates. Out of which 1269 were GNB, 41 were Gram-positive cocci and 3595 were sterile. Of these, 1269 GNB, 58 were identified as CR-GNB, according to EUCAST (2023) guidelines. The most common CR-GNB organism isolated was Klebsiella spp. (47%), followed by Escherichia coli (41%), Acinetobacter spp. (7%), and Pseudomonas aeruginosa (5%). All 58 isolates were tested for colistin susceptibility, with 4 isolates showing resistance and 54 being in the sensitive range according to EUCAST guidelines. Of the colistin-resistant isolates, 3 were Klebsiella spp. and 1 was E. coli with MICs of 16 mcg/ml, 16 mcg/ml, 8 mcg/ml, and 4 mcg/ml, respectively.

Conclusion: This colistin plate kit is a high-throughput, less time-consuming, ready-to-use method for colistin susceptibility testing in routine microbiology laboratories, which guides clinicians in lowering mortality and morbidity of CR-GNB infections by appropriate use of colistin.

Downloads

Download data is not yet available.

References

1. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791-8. doi: 10.3201/eid1710.110655, PMID 22000347.

2. Ranjan R, Iyer RN, Jangam RR, Arora N. Evaluation of in vitro colistin susceptibility and clinical profile of carbapenem-resistant Enterobacteriaceae-related invasive infections. Indian J Med Microbiol. 2023 Jan-Feb;41:40-4. doi: 10.1016/j.ijmmb.2022.12.008, PMID 36870748.

3. Lomonaco S, Crawford MA, Lascols C, Timme RE, Anderson K, Hodge DR. Resistome of carbapenem and colistin resistant Klebsiella pneumoniae clinical isolates. PLOS One. 2018 Jun 8;13(6):e0198526. doi: 10.1371/journal.pone.0198526, PMID 29883490.

4. European committee on antimicrobial susceptibility testing (EUCAST). Break point tables for interpretation of MICs and zone diameters; 2023. Available from: https://www.eucast.org.

5. CLSI performance standards for antimicrobial susceptibility testing. 32nd ed. Vol. M100. Clinical Laboratory Standard Institute; 2023. Available from: www.clsi.org/standards/products/iso-documents/documents.

6. Colistin HiMIC Plate kitMPK020 (Package insert). Maharashtra: HiMedia Laboratories; 2023.

7. Chew KL, La MV, Lin RT, Teo JW. Colistin and polymyxin B susceptibility testing for carbapenem resistant and mcr-positive Enterobacteriaceae: comparison of sensititre microscan vitek 2 and etest with broth microdilution. J Clin Microbiol. 2017;55(9):2609-16. doi: 10.1128/JCM.00268-17, PMID 28592552.

8. Mohanty S, Gaind R. In vitro susceptibility of carbapenem resistant Enterobacteriaceae to colistin: a hope at present. Indian J Med Microbiol. 2016;34(4):558-60. doi: 10.4103/0255-0857.195381, PMID 27934845.

9. Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Gennimata V, Pournaras S. Comparative evaluation of colistin susceptibility testing methods among carbapenem nonsusceptible klebsiella pneumoniae and acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2015 Aug;59(8):4625-30. doi: 10.1128/AAC.00868-15, PMID 26014928.

10. Matuschek E, Ahman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin evaluation of seven commercial mic products against standard broth microdilution for Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa and Acinetobacter spp. Clin Microbiol Infect. 2018 Aug;24(8):865-70. doi: 10.1016/j.cmi.2017.11.020, PMID 29221995.

Published

15-07-2025

How to Cite

SNEHITHA, K., et al. “THE STUDY OF COLISTIN SUSCEPTIBILITY AMONG CARBAPENEM-RESISTANT GRAM-NEGATIVE BACILLI BY BROTH MICRODILUTION METHOD USING READY-TO-USE COLISTIN MIC PLATE KIT”. International Journal of Current Pharmaceutical Research, vol. 17, no. 4, July 2025, pp. 113-6, doi:10.22159/ijcpr.2025v17i4.7037.

Issue

Section

Original Article(s)